Zoom's Rebound Is Just Getting Started

Zoom is rebounding strongly, with shares up more than 30% since early 2026 and outperforming the broader market. The article cites firming revenue growth, robust profitability, and a deeply undervalued valuation as support for a reiterated buy rating. Zoom's cash-rich balance sheet and its more than $1 billion stake in Anthropic add strategic flexibility and incremental upside.

Analysis

Zoom’s move reads less like a simple multiple re-rating and more like the market pricing a higher-quality cash compounder with optionality. The key second-order effect is that a credible AI-adjacent story can extend the stock’s investor base beyond traditional software buyers into growth and thematic capital, which often sustains valuation support even if near-term product cycles are uneven. The Anthropic stake matters not because it changes near-term earnings, but because it gives the company a narrative bridge into the AI budget pool without needing to outspend much larger platform vendors.

The competitive implication is that Zoom can defend relevance even if seat growth is muted: a richer product suite plus capital-markets optionality can slow churn and improve pricing power at the margin. That said, the market is likely extrapolating too much from balance-sheet strength into durable acceleration; the actual operating leverage still depends on enterprise IT refresh behavior and whether AI features become a monetizable reason to standardize on the platform. If those add-ons fail to move ARPU over the next 2-3 quarters, the stock can de-rate quickly because the current move has already pulled forward a meaningful amount of good news.

Contrarianly, the consensus may be underestimating how much of the upside is now tied to liquidity and sentiment rather than fundamentals. A large cash balance and private-markets stake create a floor, but they do not fully justify further multiple expansion unless there is evidence of sustained billings re-acceleration. The best risk/reward is likely in using strength to structure upside exposure rather than chasing spot, because the name is vulnerable to any wobble in software multiples or disappointment in monetization timing over a 3-6 month horizon.

Key Decisions for Investors

• Stay tactically long ZM on pullbacks over the next 4-8 weeks; favor entries after 5-7% daily or two-day air pockets rather than chasing extended strength. Upside remains tied to multiple support, but risk/reward worsens after sharp vertical moves.
• Buy ZM Jan-2027 call spreads to express continued AI/valuation optionality with defined downside. Target a structure that can win on another 15-25% upside while limiting theta bleed if the stock consolidates.
• Pair trade: long ZM / short a lower-quality unprofitable SaaS peer basket over 1-3 months. The trade benefits if the market keeps rewarding cash flow and balance-sheet strength while punishing weaker software names.
• Trim into strength if ZM trades at a clear premium to software index multiples without evidence of billings or ARPU inflection. The stock is likely to be more sensitive to any guidance miss than the broader market assumes.
• Set a catalyst watch on the next earnings call and any disclosure around Anthropic-related strategic initiatives; if management cannot connect the investment to measurable product monetization within 1-2 quarters, the AI narrative may fade as a valuation driver.